111, Inc. (YI)
3.61
-0.13
(-3.48%)
USD |
NASDAQ |
Dec 12, 16:00
3.64
+0.03
(+0.83%)
After-Hours: 20:00
111 EPS Diluted (Quarterly): -0.3114 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | -0.1682 |
| CASI Pharmaceuticals, Inc. | -0.6781 |
| Zai Lab Ltd. | -0.3267 |
| Adagene, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.757M |
| Revenue (Quarterly) | 443.21M |
| Total Expenses (Quarterly) | 445.91M |
| Enterprise Value | 128.39M |
| Gross Profit Margin (Quarterly) | 5.78% |
| Profit Margin (Quarterly) | -0.62% |
| Earnings Yield | -26.01% |
| Normalized Earnings Yield | -26.01 |